| Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433 S Monro, KL Colon, H Yin, J Roque III, P Konda, S Gujar, RP Thummel, ... Chemical reviews 119 (2), 797-828, 2018 | 791 | 2018 |
| ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ... Cell Death & Differentiation 27 (1), 363-378, 2020 | 75 | 2020 |
| Near-infrared absorbing Ru (II) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma LM Lifshits, JA Roque III, P Konda, S Monro, HD Cole, D von Dohlen, ... Chemical science 11 (43), 11740-11762, 2020 | 55 | 2020 |
| MHC-I ligand discovery using targeted database searches of mass spectrometry data: implications for T-cell immunotherapies JP Murphy, P Konda, DJ Kowalewski, H Schuster, D Clements, Y Kim, ... Journal of Proteome Research 16 (4), 1806-1816, 2017 | 48 | 2017 |
| Cytokines in oncolytic virotherapy JG Pol, ST Workenhe, P Konda, S Gujar, G Kroemer Cytokine & Growth Factor Reviews 56, 4-27, 2020 | 29 | 2020 |
| RTN4 knockdown dysregulates the AKT pathway, destabilizes the cytoskeleton, and enhances paclitaxel-induced cytotoxicity in cancers GP Pathak, R Shah, BE Kennedy, JP Murphy, D Clements, P Konda, ... Molecular Therapy 26 (8), 2019-2033, 2018 | 29 | 2018 |
| Multiplexed relative quantitation with isobaric tagging mass spectrometry reveals class I major histocompatibility complex ligand dynamics in response to doxorubicin JP Murphy, Q Yu, P Konda, JA Paulo, MP Jedrychowski, DJ Kowalewski, ... Analytical chemistry 91 (8), 5106-5115, 2019 | 25 | 2019 |
| Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic ReovirusOncolytic Reovirus in Combination with PDH Reprogramming BE Kennedy, JP Murphy, DR Clements, P Konda, N Holay, Y Kim, ... Cancer research 79 (15), 3824-3836, 2019 | 22 | 2019 |
| Therapy-induced MHC I ligands shape neo-antitumor CD8 T cell responses during oncolytic virus-based cancer immunotherapy JP Murphy, Y Kim, DR Clements, P Konda, H Schuster, DJ Kowalewski, ... Journal of proteome research 18 (6), 2666-2675, 2019 | 22 | 2019 |
| Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus-independent host genes, via mechanisms of slow replication versus polymorphisms in … A Mohamed, P Konda, HE Eaton, S Gujar, JR Smiley, M Shmulevitz PLoS Pathogens 16 (9), e1008803, 2020 | 19 | 2020 |
| Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy P Konda, LM Lifshits, JA Roque III, HD Cole, CG Cameron, SA McFarland, ... Oncoimmunology 10 (1), 1863626, 2021 | 16 | 2021 |
| Quantitative temporal in vivo proteomics deciphers the transition of virus-driven myeloid cells into M2 macrophages DR Clements, JP Murphy, A Sterea, BE Kennedy, Y Kim, E Helson, ... Journal of proteome research 16 (9), 3391-3406, 2017 | 16 | 2017 |
| Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell … P Konda, JA Roque III, LM Lifshits, A Alcos, E Azzam, G Shi, CG Cameron, ... American Journal of Cancer Research 12 (1), 210, 2022 | 10 | 2022 |
| Immune checkpoint blockade augments changes within oncolytic virus-induced cancer MHC-I peptidome, creating novel antitumor CD8 T cell reactivities Y Kim, P Konda, JP Murphy, JA Paulo, SP Gygi, S Gujar Molecular & Cellular Proteomics 21 (2), 2022 | 4 | 2022 |
| Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis SP Holman, AS Lobo, RJ Novorolsky, M Nichols, MDJ Fiander, P Konda, ... Experimental Neurology 333, 113430, 2020 | 4 | 2020 |
| Genetic polymorphisms and molecular mechanisms mediating oncolytic potency of reovirus strains A Mohamed, DR Clements, P Konda, SA Gujar, PW Lee, JR Smiley, ... bioRxiv, 569301, 2019 | 2 | 2019 |
| Improving MHC‐I Ligand Identifications from LC‐MS/MS Data by Incorporating Allelic Peptide Motifs P Konda, JP Murphy, S Gujar Proteomics 19 (5), 1800458, 2019 | 2 | 2019 |
| Enhancing mass spectrometry-based MHC-I peptide identification through a targeted database search approach P Konda, JP Murphy, M Nielsen, S Gujar Immunoproteomics: Methods and Protocols, 301-307, 2019 | 2 | 2019 |
| NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma BE Kennedy, M Giacomantonio, JP Murphy, S Cutler, M Sadek, P Konda, ... Molecular Therapy-Oncolytics 24, 695-706, 2022 | 1 | 2022 |
| Improving MHC-I ligand identification by incorporating targeted searches of mass spectrometry data P Konda, JP Murphy, S Gujar Bioinformatics for Cancer Immunotherapy: Methods and Protocols, 161-171, 2020 | 1 | 2020 |
